Tobi Martin, Zhao Xiaoqing, Rodriquez Rebecca, Tobi Yosef Y, Ganguly Tapan, Kuhn Donald, McVicker Benita, Lawson Michael J, Lieb John, Lopes Jaime L
Department of Research and Development, Detroit John D. Dingle VAMC, Detroit, MI 48201, USA.
Central Michigan University, Saginaw Campus, 1632 Stone St., Saginaw, MI 48602, USA.
Gastrointest Disord (Basel). 2024 Jun 7;6(2):497-512. doi: 10.3390/gidisord6020034.
Colorectal cancer (CRC) outcomes in terms of incidence and mortality are significantly worse in African Americans than other Americans. While differences in primary preventions for neoplasia (diet, obesity remediation, aspirin prophylaxis) are being elucidated, genetic mutations affecting premalignant lesions and immune response mechanisms may possibly also explain the increased incidence and mortality, particularly from right-sided disease.
Our team therefore examined colonic segments seeking to test the hypothesis that the immune response and somatic genetic profiles of the colonic anatomic segments may vary and thus account for variations in neoplasia risk among the various colonic segments revealing an antigenic relationship with precancerous lesions. The p87 antigenic field effect is recognized via Adnab-9 antibody immunohistochemistry to be significantly less in the right colon in African Americans, particularly in the cecum.
Since small high-grade dysplastic adenomas (SHiGDA) likely missed by CRC screening may progress to cancer, we used Ion Torrent sequencing of DNA extracted from four normal colonic segments (two left-sided and two right) of patients with SHiGDAs. We also contrasted unique mutational fields in one patient with a large HiGDA ( with unique mutations) and one patient who prospectively developed a SHiGDA ().
The SHiGDA (small high-grade dysplastic polyp) patient was p87 negative for any extracted stool, saliva, or colonic effluent via ELISA (enzyme linked immunoadsorbant assay). Furthermore, mean values of expression in segments from the right colon were reduced with respect to the means obtained from the left segments in 233 patients evaluated for a p87 field effect. This has recently been shown to be the case in a large cohort of AA and Caucasian 2294 patients, possibly explaining the right-sided CRC disparity in African Americans and the subsequent increase in mortality. This field effect disparity is also true for two cancers contracted by the SHiGDa patient (lung and prostate).
Thus, this pilot study suggests that the reduction in p87 in the right colon is possibly correlated with mutations. If confirmed, mutations, known to be associated with immune aberrations, may provide a mechanistic explanation for the lack of a p87 (protein 87 kilodaltons) field in some patients with HGD polyps who might benefit from possible intervention such as more intensive screening. Limited microbiome studies were also performed on two patients with familial cancer syndromes and these compared favorably with controls available from the literature.
非裔美国人的结直肠癌(CRC)在发病率和死亡率方面的结果明显比其他美国人更差。虽然肿瘤形成的一级预防(饮食、肥胖症治疗、阿司匹林预防)方面的差异正在被阐明,但影响癌前病变和免疫反应机制的基因突变也可能解释发病率和死亡率的增加,特别是右侧疾病的情况。
因此,我们的团队检查了结肠段,试图验证以下假设:结肠解剖段的免疫反应和体细胞基因特征可能不同,从而解释不同结肠段之间肿瘤形成风险的差异,揭示与癌前病变的抗原关系。通过Adnab-9抗体免疫组织化学法识别出p87抗原场效应在非裔美国人的右结肠中明显较低,特别是在盲肠中。
由于CRC筛查可能遗漏的小的高级别发育异常腺瘤(SHiGDA)可能会发展为癌症,我们对患有SHiGDA的患者的四个正常结肠段(两个左侧和两个右侧)提取的DNA进行了Ion Torrent测序。我们还对比了一名患有大的高级别发育异常腺瘤(有独特突变)的患者和一名前瞻性发展为SHiGDA的患者的独特突变区域。
通过酶联免疫吸附测定(ELISA),SHiGDA(小的高级别发育异常息肉)患者的任何提取粪便、唾液或结肠流出物的p87均为阴性。此外,在评估p87场效应的233名患者中,右结肠段的表达平均值相对于左结肠段获得的平均值有所降低。最近在一大群非裔美国人和白人2294名患者中也发现了这种情况,这可能解释了非裔美国人右侧CRC的差异以及随后死亡率的增加。这种场效应差异在SHiGDa患者患的两种癌症(肺癌和前列腺癌)中也存在。
因此,这项初步研究表明,右结肠中p87的减少可能与突变有关。如果得到证实,已知与免疫异常相关的突变可能为一些患有高级别发育异常息肉的患者缺乏p87(87千道尔顿蛋白)场效应提供一个机制解释,这些患者可能从更密集筛查等可能的干预措施中受益。还对两名患有家族性癌症综合征的患者进行了有限的微生物组研究,与文献中的对照组相比结果良好。